Skip to main content
European Consortium of Lipodystrophies (ECLip)
  • Home
  • Goals
  • Lipodystrophies
    • Classification
  • Groups
    • Austria
      • Foisner
      • Scherer
    • Belgium
      • Unité de Recherche en Biologie Cellulaire (Namur)
      • Cell Systems and Imaging (Ghent)
      • Universitair Ziekenhuis Antwerpen (Antwerp)
    • Bulgaria
    • Cuba
    • Cyprus
    • Egypt
    • France
      • Paris-Saint-Antoine PRISIS-Inserm UMR_S938 team
      • Genetics, Pathophysiology and Therapeutic Approach
      • Paediatric Endocrinology Unit (Paris)
      • INSERM UMR_S 1087 (Nantes)
      • Lille Group (Lille)
      • ​Premature Aging Syndromes & Lipodystrophies​
      • Pediatric Endocrinology and Diabetology (Paris)
    • Germany
      • Hoffmann Group (Halle)
      • Clinic for Transplantation Medicine (Münster)
      • Dep. of Pediatrics and Adolescent Medicine (Ulm)
      • IFB Lipodystrophy Centre (Leipzig)
    • Greece
      • ​Paediatric HIV Referral Unit (Athens)
      • Unit of Reproductive Endocrinology (Thessaloniki)
    • Israel
    • Italy
      • Laminopathy Research Laboratory (Bologna)
      • Human Lipodystrophies (Bologna)
      • Obesity Center-Endocrinology Unit (Pisa)
      • Laboratory of Medical Genetics (Roma)
      • Gene Expression - Microarrays Laboratory (Roma)
    • Lithuania
    • Netherlands
      • AMC Lipodystrophy Group (Amsterdam)
      • Maastricht University Hospital
      • Leiden University Medical Center
      • Amsterdam UMC
    • Norway
    • Oman
    • Peru
    • Poland
    • Portugal
      • Porto University
      • Grupo de Estudo das Lipodistrofias do CMIN (Porto)
    • Russia
      • ERC
      • RLSG
    • Serbia
    • Slovenia
    • Spain
      • UETeM - Molecular Pathology Group (Santiago)
      • Stem Cell Laboratory (Vizcaya)
      • Rheumatology Division Proteomics Group (A Coruña)
      • Department of Medical Sciences (Ciudad Real)
      • Adipobiology Group (Córdoba)
      • Uniovi (Oviedo)
      • Dep. Biochemistry & Molecular Biology (Barcelona)
      • Clinical Genetics and Rare Diseases (Murcia)
      • Fundación Galega de Medicina Xenómica (Santiago)
      • Complement system IdiPAZ (Madrid)
    • Sweden
    • Switzerland
    • Taiwan
    • Turkey
    • United Arab Emirates
    • United Kingdom
      • Nat. Severe Insulin Resistance Service (Cambridge)
      • Centre for Cardiovascular Science (Edinburgh)
      • University of Aberdeen
    • USA
      • NIDDK (Maryland)
      • University of Michigan
  • Information
    • Advocacy groups
    • Clinical centres
    • Executive board
      • Disclosure
    • Registry
  • News
  • Meetings
    • 2015 World Lipodystrophy Day
    • 2016 ECLip Annual Meeting
    • 2017 ECLip Annual Meeting
    • 2018 ECLip Annual Meeting
    • 2019 ECLip Annual Meeting
      • Gallery
    • 2020 ECLip Annual Meeting
    • 2022 ECLip Annual Meeting
    • 2023 ECLip Annual Meeting
    • 2025 ECLip Annual Meeting
  • Publications
    • Lipodystrophy papers of the month
    • Collaborative ECLip Publications
  • Contact
  • Ask the experts

Disclosure


PRESIDENT

Prof. David Araújo-Vilar, University of Santiago de Compostela, Spain
Conflict of interest
 
 

VICE-PRESIDENT
Prof. Martin Wabitsch, University Medical Center Ulm, Germany
Conflict of interest


SECRETARY
Prof. Corinne Vigouroux, Sorbonne University, Paris, France
Conflict of interest


TREASURER
Prof. Ferrucio Santini, University of Pisa, Italy
Conflict of interest

 

BOARD MEMBER

Prof. Justin Rochford, University of Aberdeen, United Kingdom
Conflict of interest
 
 

BOARD MEMBER
Prof. Robert Semple, University of Edinburgh, United Kingdom
Conflict of interest


BOARD MEMBER
Prof. Baris Akinci, Dokuz EylulUniversity School of Medicine, Izmir, Turkey
Dr. Akinci is a compensated consultant for Amryt Pharmaceuticals. Dr. Akinci serves as a consultant, add board member, steering committee member, and/or speaker to Regeneron, Third Rock Ventures, AstraZeneca, Novonordisk, Boehringer Ingelheim, Sanofi, Novartis, Bilim Ilac, ARIS, and Servier.


BOARD MEMBER
Prof. Elif Oral, University of Michigan, USA
Conflict of interest

2019 European Consortium of Lipodystrophies (ECLip)